Surgical advances in the treatment of adults with congenital heart disease

Current Opinion in Pediatrics

Volumn 21, Issue 5, 2009, Pages 565-572

  Dearania, Joseph A ^a   Mavroudisb, Constantine ^b   Quintessenzac, James ^c   Deald, Barbara J ^d   Backerd, Carl L ^d   Fitzgeralda, Patrick ^a   Connollya, Heidi M ^a   Jacobsc, Jeffrey P ^c  

^a MAYO CLINIC   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Division of Pediatric Heart Surgery   (United States)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Ebstein anomaly; Fontan procedure; Pulmonary valve replacement; Tetralogy of Fallot

Indexed keywords

ADULT; ARTIFICIAL HEART PACEMAKER; CASE MANAGEMENT; EBSTEIN ANOMALY; FONTAN PROCEDURE; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE FAILURE; HUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLITEF IMPLANT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY VALVE DISEASE; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE REPLACEMENT; REOPERATION; REVIEW; SUDDEN DEATH; TREATMENT INDICATION;

ADULT; EBSTEIN ANOMALY; FONTAN PROCEDURE; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PULMONARY VALVE INSUFFICIENCY; TRICUSPID ATRESIA;

EID: 73349102763     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283303fa7     Document Type: Review

References (53)

1. Dearani JA, O'Leary PW, Danielson GK. Surgical treatment of Ebstein malformation: state of the art in 2006. Cardiol Young 2006; 16:12-20.
2. Celermajer DS, Bull C, Till JA, et al. Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 1994; 23:170-176.
3. Brown ML, Dearani JA, Danielson GK, et al. The outcome of operation for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg 2008; 135:1120-1136. This study reports the early and late results of the largest surgical series of Ebstein anomaly. A detailed analysis of numerous variables was performed with risk factors for early and late survival.
4. Dearani JA, Bacha E, da Silva JP. Cone reconstruction of the tricuspid valve for Ebstein anomaly: anatomic repair. Oper Tech Thorac Cardiovasc Surg 2008; 13:109-125. This study goes through a step-by-step sequence of diagrams of how the cone repair (near anatomic repair) is performed.
5. Boston US, Dearani JA, O'Leary PW, et al. Tricuspid valve repair for Ebstein anomaly in young children: a 30-year experience. Ann Thorac Surg 2006; 81:690-695.
6. Kiziltan HT, Theodoro DA, Warnes CA, et al. Late results of bioprosthetic tricuspid valve replacement in Ebstein anomaly. Ann Thorac Surg 1998; 66:1539-1545.
7. da Silva JP, Baumgratz FJ, Fonseca L, et al. The cone reconstruction of the tricuspid valve in Ebstein anomaly. The Operation: early and midterm results. J Thorac Cardiovasc Surg 2007; 133:215-223.
8. Chauvaud S. Ebstein malformation. Surgical treatment and results. J Thorac Cardiovasc Surg 2000; 48:220-223.
9. Quaegebeur JM, Sreeram N, Fraser AG, et al. Surgery for Ebstein anomaly the clinical and echocardiographic evaluation of a new technique. J Am Coll Cardiol 1991; 17:722-728.
10. Chen JM, Mosca RS, Altmann K, et al. Early and medium-term results for repair of Ebstein anomaly. J Thorac Cardiovasc Surg 2004; 127:990-999.
11. Sarris GE, Giannopoulos NM, Tsoutsinos AJ, et al. Results of surgery for Ebstein anomaly: a multicenter study from the European Congenital Heart Surgeons Association. J Thorac Cardiovasc Surg 2006; 132: 50-57.
12. Mavroudis C, Deal BJ, Back CL, et al. Arrhythmia surgery in patients with and without congenital heart disease. Ann Thorac Surg 2008; 86:857-868. Strategies and methods for the surgical treatment of arrhythmias in patients with and without CHD are reviewed.
13. Stulak JM, Dearani JA, Puga FJ, et al. Right-sided maze procedure for atrial tachyarrhythmias in congenital heart disease. Ann Thorac Surg 2006; 81:1780-1784.
14. Khositseth A, Danielson GK, Dearani JA, et al. Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg 2004; 128:826-833.
15. Greason KL, Dearani JA, Theodoro DA, et al. Surgical management of atrial tachyarrhythmias associated with congenital cardiac anomalies: Mayo Clinic experience. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2003; 6:59-71.
16. Brown ML, Dearani JA, Danielson GK, et al. Functional status after operation for Ebstein anomaly: the Mayo Clinic experience. J Am Coll Cardiol 2008; 52:460-466.
17. Mavroudis C, Backer CL, Deal BJ, et al. Evolving anatomic and electrophysiologic considerations associated with Fontan conversion. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2007; 10:136-145.
18. Backer CL, Deal BJ, Mavroudis C, et al. Conversion of the failed Fontan circulation. Cardiol Young 2006; 16 (Suppl 1):85-91.
19. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26:240-248.
20. Fontan F, Deville C, Quaegebeur J, et al. Repair of tricuspid atresia in 100 patients. J Thorac Cardiovasc Surg 1983; 85:647-660.
21. Kreutzer G, Galindez E, Bono H, et al. An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg 1973; 66:613-621.
22. de Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 1988; 96:682-695.
23. Marcelletti C, Corno A, Giannico S, Marino B. Inferior vena cava-pulmonary artery extracardiac conduit. A new form of right heart bypass. J Thorac Cardiovasc Surg 1990; 100:228-232. (Pubitemid 20255234)
24. Kao JM, Alejos JC, Grant PW, et al. Conversion of atriopulmonary to cavopulmonary anastomosis in management of late arrhythmias and atrial thrombosis. Ann Thorac Surg 1994; 58:1510-1514.
25. Laks H, Ardehali A, Grant PW, et al. Modification of the Fontan procedure. Superior vena cava to left pulmonary artery connection and inferior vena cava to right pulmonary artery connection with adjustable atrial septal defect. Circulation 1995; 91:2943-2947.
26. Mavroudis C, Backer CL, Deal BJ, Johnsrude CL. Fontan conversion to cavopulmonary connection and arrhythmia circuit cryoblation. J Thorac Cardiovasc Surg 1998; 115:547-556.
27. Mavroudis C, Deal BJ, Backer CL. Venous shunts and the Fontan circulation for congenital heart disease. In: Gatzoulis MA, ed. Diagnosis management of adult congenital heart disease. 2nd ed. (in press).
28. Mavroudis C, Backer CL, Deal BJ. Late reoperations for Fontan patients: state of the art invited review. Eur J Cardiothorac Surg 2008; 34:1034-1040.
29. Alfieri O, Maisano F. An effective technique to correct anterior mitral leaflet prolapse. J Card Surg 1999; 14:468-470.
30. Zias EA, Mavroudis C, Backer CL, et al. Surgical repair of the congenitally malformed mitral valve in infants and children. Ann Thorac Surg 1998; 66:1551-1559.
31. Mavroudis C, Deal BJ, Backer CL, et al. J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. Ann Thorac Surg 2007; 84:1457-1465; discussion 1465-1466. This study reports the largest series of patients undergoing Fontan conversion with concomitant maze procedure. A detailed analysis of risk factors and diagrams of the antiarrhythmia procedure are outlined.
32. Mavroudis C, Deal BJ, Backer CL. Surgery for arrhythmias and pacemakers in children. In: Sellke FW, del Nido PJ, Swanson SJ, editors. Sabiston & Spencer surgery of the chest, 7th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2005. pp. 2259-2279.
33. Shaddy RE, Hunter DD, Osborn KA, et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation 1996; 94:1063-1067.
34. Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005; 26:433-439.
35. Frigiola A, Redington AN, Cullen S. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation 2004; 110 (Suppl l): 153-157.
36. Matsoukis MA, Balladic S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicenter study. Lancet 2000; 356:975-981.
37. Geva,T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Ped Card Surg Annu 2006:11-22.
38. Bove EL, Kavey RE, Byrum CJ, et al. Improved right ventricular function following late pulmonary valve replacement for residual pulmonary regurgitation or stenosis. J Thorac Cardiovasc Surg 1985; 90:50-55.
39. Ammash NM, Dearani JA, Burkhart HM, et al. Pulmonary regurgitation after tetralogy of Fallot: clinical features, sequelae, and timing of pulmonary valve replacement. Cong Heart Dis 2007; 2:386-403.
40. van Straten A, Vliegen HW, Hazekamp MG, et al. Right ventricular function after pulmonary valve replacement in patients with tetralogy of Fallot. Radiology 2004; 233:824-829.
41. Therrien J, Siu SC, McLaughlin PR, et al. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: are we operating too late? J Am Coll Cardiol 2000; 36:1670-1675.
42. Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001; 103:2489-2494.
43. Hawkins JA, Sower CT, Lambert LM, et al. Stentless porcine valves in the right ventricular outflow tract: improved durability. Eur J Cardiothorac Surg 2009; 35:600-604; discussion 604-605. This study analyzes intermediate-term performance of stentless porcine valves in the right ventricular outflow tract in 150 children and adults over a 10-year period and concludes that these valves function well in the pulmonary position over the intermediate term and are associated with low rates of reintervention in patients requiring a more than 19-mm valve or valved conduit. Longer-term follow-up and comparison with other alternatives will be necessary to determine whether these valves are superior to commonly used allograft or bovine jugular venous valved conduits.
44. Kanter KR, Budde JM, Parks WJ, et al. One hundred pulmonary valve replacements in children after relief of right ventricular outflow tract obstruction. Ann Thorac Surg 2002; 73:1801-1806; discussion 1806-1807.
45. Fiore AC, Rodefeld M, Turrentine M, et al. Pulmonary valve replacement: comparison of three biologic valves. Ann Thorac Surg 2008; 85:1712-1718. This article reviews the performance of the mosaic porcine, bovine pericardial, and homograft prostheses for PVR to correct chronic pulmonary insufficiency. The authors conclude that 'All three prostheses performed similarly for 3 years. Pulmonary regurgitation developed more frequently in homografts, although at a longer duration of follow-up'.
46. Soor GS, Leong SW, Butany J, et al. Pulmonary bioprosthesis: morphologic findings in 40 cases. Arch Pathol Lab Med 2009; 133:797-802. This study analyzes a consecutive series of 40 explanted nonhomograft pulmonarysite bioprostheses. The authors conclude that 'Explanted bioprostheses showed a high degree of calcification and pannus, which together led to stenosis. Cusp immobilization, involving all three cusps, was frequent and was more common in patients younger than 30 years of age at explantation (P≤0.001). Host-tissue overgrowth is a significant problem with bioprostheses, and pulmonary-site bioprostheses are no exception'.
47. Hawkins JA, Breinholt JP, Lambert LM, et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg 2000; 119:324-330.
48. Waterbolk TW, Hoendermis ES, den Hamer IJ, Ebels T. Pulmonary valve replacement with a mechanical prosthesis. Promising results of 28 procedures in patients with congenital heart disease. Eur J Cardiothorac Surg 2006; 30:28-32.
49. Quintessenza JA, Jacobs JP, Chai PJ, et al. Late replacement of the pulmonary valve: when and what type of valve? Cardiol Young 2005; 15 (Suppl 1):58-63.
50. Quintessenza JA, Jacobs JP, Morell VO, et al. The initial experience with a bicuspid polytetrafluoroethylene pulmonary valve in 41 children and adults: a new option for right ventricular outflow tract reconstruction. Ann Thorac Surg 2005; 79:924-931.
51. Quintessenza JA. Polytetrafluoroethylene bicuspid pulmonary valve implantation. Oper Tech Thorac Cardiovasc Surg 2009; 13:244-249. This study describes the operative technique used in the largest series of patients undergoing PVR with a man-made hand-sewn PTFE bicuspid valve. At present, there are more than 110 patient implants with follow-up extending out to 8 years. Initially, the valve was made from porous 0.6-mm PTFE, but the current technique utilizes nonporous 0.1-mm PTFE, which does not allow cellular ingrowth and thickening.
52. Frigiola A, Nordmeyer J, Bonhoeffer P, et al. Percutaneous pulmonary valve replacement. Coron Artery Dis 2009; 20:189-191. This study discusses the clinical indications and early results of percutaneous transcatheter PVR. The senior author is the inventor and developer of the technique, Philipp Bonhoeffer.
53. Mayer J. Tissue engineering for cardiac valve surgery. In: Cohn L, editor. Cardiac surgery in the adult, 3rd ed. New York: McGraw-Hill; 2008. pp. 1649-1656.